Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Blood Advances
|
February 26, 2021
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Matthew L Meizlish, Alexander B Pine, Jason D Bishai, et al.
Nature Genetics
|
January 24, 2017
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Jasmijn D E de Rooij, Cristyn Branstetter, Jing Ma, et al.
Nature Communications
|
April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
The Journal of Clinical Investigation
|
December 30, 2025
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironment
Sisi Chen, Sergio Barajas, Sasidhar Vemula, et al.
Leukemia
|
October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Blood Advances
|
October 19, 2022
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, et al.
Blood
|
March 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Uma Borate, Kelly Pugh, Allyson Waller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Blood Advances
|
February 26, 2021
A neutrophil activation signature predicts critical illness and mortality in COVID-19
Matthew L Meizlish, Alexander B Pine, Jason D Bishai, et al.
Nature Genetics
|
January 24, 2017
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Jasmijn D E de Rooij, Cristyn Branstetter, Jing Ma, et al.
Nature Communications
|
April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
The Journal of Clinical Investigation
|
December 30, 2025
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironment
Sisi Chen, Sergio Barajas, Sasidhar Vemula, et al.
Leukemia
|
October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Blood Advances
|
October 19, 2022
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, et al.
Blood
|
March 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Uma Borate, Kelly Pugh, Allyson Waller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
Page
of 13